Nexentis Technologies Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
NXTS chart
What traders are saying about $NXTS
Latest postsNexentis Technologies Inc. news
- Nexentis Technologies Inc. (NXTS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Nexentis Technologies Inc. (NXTS) stock price, news, quote and history
Yahoo Finance UK ·
- MitoCareX Bio completes initial AI-driven drug screening, advancing its drug discovery efforts.
Pluang ·
- Nexentis Technologies Reports Initial Computational Screening Results in MitoCareX Drug-Discovery Collaboration with Boltz
Quiver Quantitative ·
- Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
Yahoo Finance ·
- A director receives 14,795 restricted shares in Nexentis Technologies (NXTS) through Aka Optic Ltd.
Stock Titan ·
- Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
Yahoo Finance ·
- Nexentis Deploys MitoCareX Computational Drug Discovery Infrastructure on Google Cloud
investorshub.advfn.com ·
- Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
Yahoo Finance ·
- Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
Yahoo Finance ·
- Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
Yahoo Finance ·
- Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign
Yahoo Finance ·
Nexentis Technologies Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $210,000 | $263,000 | $394,004 |
| Net income | -$4.0M | -$5.2M | -$6.5M | -$5.7M |
| Diluted EPS | $-8.61 | $-27.74 | $-5.43 | $10.85 |
| Total assets (year end) | $20.4M | $5.5M | $7.2M | $6.5M |
| Cash and equivalents (year end) | $3.8M | $1.9M | $4.4M | $5.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nexentis Technologies Inc.
- Ticker
- NXTS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1789192
- Former names
- N2OFF, Inc., Save Foods, Inc., Save Foods Inc.
Frequently asked questions
What exchange is Nexentis Technologies Inc. listed on?
Nexentis Technologies Inc. trades on the Nasdaq under the ticker symbol NXTS.
What industry is Nexentis Technologies Inc. in?
Nexentis Technologies Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nexentis Technologies Inc. headquartered?
Nexentis Technologies Inc.'s business address on file with the SEC is in New York, NY.
When does Nexentis Technologies Inc.'s fiscal year end?
Nexentis Technologies Inc.'s fiscal year ends on December 31.
How much revenue did Nexentis Technologies Inc. report?
Nexentis Technologies Inc. reported $210,000 in revenue for calendar year 2024, according to its SEC filings.